Non Small Cell Lung Cancer

Showing NaN - NaN of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +212 more
Jan 26, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Non Small Cell Lung Cancer Trial in Hong Kong, Netherlands, Spain (Pulsed electric field treatment using the Aliya System)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Pulsed electric field treatment using the Aliya System
  • Sha Tin, Hong Kong
  • +3 more
Jan 6, 2023

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +58 more
Dec 13, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Zirabev)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Angers, France
  • +30 more
Oct 31, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +29 more
Sep 21, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 8, 2022

Non Small Cell Lung Cancer Trial in Spain (Paclitaxel, Carboplatin, Nivolumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +24 more
Aug 5, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Non Small Cell Lung Cancer Trial in France, Korea, Republic of, Spain (Fexofenadine tablet dosing, Osimertininb tablet dosing)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Fexofenadine tablet dosing
  • Osimertininb tablet dosing
  • Rennes Cedex 9, France
  • +6 more
Jul 4, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Non Small Cell Lung Cancer Trial in Spain (Atezolizumab-Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +24 more
Jun 1, 2022

Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer Trial in Spain (Ipilimumab, Nivolumab, Carboplatin)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Badalona, Barcelona, Spain
  • +17 more
Jun 1, 2022

Osimertinib in Advanced Non-Small Cell Lung Cancer EGFR-T790M

Completed
  • Non Small Cell Lung Cancer
  • Oviedo, Asturias, Spain
  • +30 more
Jun 1, 2022

Non Small Cell Lung Cancer Trial in Spain (Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +11 more
May 4, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Glendale, Arizona
  • +135 more
Feb 28, 2022

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer, Melanoma Trial in Worldwide (MGC018, retifanlimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +5 more
  • MGC018
  • retifanlimab
  • Santa Monica, California
  • +19 more
Feb 14, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Chandler, Arizona
  • +181 more
Feb 4, 2022